Edward Pershing serves as Executive at PROVECTUS BIOPHARMACEUTICALS, INC., where they oversee executive responsibilities. Since joining the company, Edward Pershing has executed 2 insider transactions totaling $100.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Feb 9, 2026 involved purchasing 34,940 shares valued at $100.0K.
Edward Pershing currently holds 2,613,807 shares of PROVECTUS BIOPHARMACEUTICALS, INC. (PVCT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Edward Pershing has been a net buyer of PVCT stock. They have purchased $100.0K and sold $0 worth of shares.
Edward Pershing's most recent insider trade was on Feb 9, 2026, when they purchased 34,940 shares at $2.86 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |